Literature DB >> 25689356

Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.

Song Yang1, Ross L Prentice.   

Abstract

For risk and benefit assessment in clinical trials and observational studies with time-to-event data, the Cox model has usually been the model of choice. When the hazards are possibly non-proportional, a piece-wise Cox model over a partition of the time axis may be considered. Here, we propose to analyze clinical trials or observational studies with time-to-event data using a certain semiparametric model. The model allows for a time-dependent treatment effect. It includes the important proportional hazards model as a sub-model and can accommodate various patterns of time-dependence of the hazard ratio. After estimation of the model parameters using a pseudo-likelihood approach, simultaneous confidence intervals for the hazard ratio function are established using a Monte Carlo method to assess the time-varying pattern of the treatment effect. To assess the overall treatment effect, estimated average hazard ratio and its confidence intervals are also obtained. The proposed methods are applied to data from the Women's Health Initiative. To compare the Women's Health Initiative clinical trial and observational study, we use the propensity score in building the regression model. Compared with the piece-wise Cox model, the proposed model yields a better model fit and does not require partitioning of the time axis.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  average hazard ratio; censored data; hazard ratio; nonproportional hazards; semiparametric analysis; simultaneous inference

Mesh:

Year:  2015        PMID: 25689356      PMCID: PMC4393788          DOI: 10.1002/sim.6453

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  19 in total

1.  Explained randomness in proportional hazards models.

Authors:  John O'Quigley; Ronghui Xu; Janez Stare
Journal:  Stat Med       Date:  2005-02-15       Impact factor: 2.373

2.  The estimation of average hazard ratios by weighted Cox regression.

Authors:  Michael Schemper; Samo Wakounig; Georg Heinze
Journal:  Stat Med       Date:  2009-08-30       Impact factor: 2.373

3.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

4.  A simulation study of predictive ability measures in a survival model I: explained variation measures.

Authors:  Babak Choodari-Oskooei; Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2011-04-26       Impact factor: 2.373

5.  Checking semiparametric transformation models with censored data.

Authors:  Li Chen; D Y Lin; Donglin Zeng
Journal:  Biostatistics       Date:  2011-07-23       Impact factor: 5.899

6.  Semiparametric inference on the absolute risk reduction and the restricted mean survival difference.

Authors:  Song Yang
Journal:  Lifetime Data Anal       Date:  2013-02-08       Impact factor: 1.588

7.  Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Authors:  Ross L Prentice; Robert Langer; Marcia L Stefanick; Barbara V Howard; Mary Pettinger; Garnet Anderson; David Barad; J David Curb; Jane Kotchen; Lewis Kuller; Marian Limacher; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2005-07-20       Impact factor: 4.897

8.  Efficient semiparametric estimation of short-term and long-term hazard ratios with right-censored data.

Authors:  Guoqing Diao; Donglin Zeng; Song Yang
Journal:  Biometrics       Date:  2013-11-04       Impact factor: 2.571

9.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

View more
  4 in total

1.  A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Authors:  Song Yang; Walter T Ambrosius; Lawrence J Fine; Adam P Bress; William C Cushman; Dominic S Raj; Shakaib Rehman; Leonardo Tamariz
Journal:  Clin Trials       Date:  2018-04-19       Impact factor: 2.486

2.  How to control for unmeasured confounding in an observational time-to-event study with exposure incidence information: the treatment choice Cox model.

Authors:  James Troendle; Eric Leifer; Zhiwei Zhang; Song Yang; Heather Tewes
Journal:  Stat Med       Date:  2017-07-04       Impact factor: 2.373

3.  Prostate cancer survival estimates: An application with piecewise hazard function derivation.

Authors:  Atanu Bhattacharjee; Atul Budukh; Rajesh Dikshit
Journal:  South Asian J Cancer       Date:  2019 Jul-Sep

4.  Examining evidence of time-dependent treatment effects: an illustration using regression methods.

Authors:  Kim M Jachno; Stephane Heritier; Robyn L Woods; Suzanne Mahady; Andrew Chan; Andrew Tonkin; Anne Murray; John J McNeil; Rory Wolfe
Journal:  Trials       Date:  2022-10-06       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.